semaglutide and heart attack HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of cardiovascular death, attack, stroke, heart failure, ALL CAUSE MORTALITY! Groundbreaking SELECT Semaglutide: The NHS's New Weapon
Description
Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes
Concurrently with reductions in glycemia and body weight, retatrutide dose-dependently reduced systolic and diastolic blood pressure and improved lipid profiles, notably reducing non-HDL-C concentrations while decreasing triglyceride by up to 35% (Rosenstock et al
Secondary outcomes were as follows: total and chronic (from 6 months on) eGFR slopes
doi: 10.1111/nyas.12081 191 de DeusIJOliveiraAFCostaLSAlmeidaJFNascimentoDS
Works With Your Bodys Natural Fullness Hormone
